412950-08-4,MFCD13195581
Catalog No.:AA00CL7R

412950-08-4 | 2-[[(2,3-Difluorophenyl)methyl]thio]-N-[1-(2-methoxyethyl)-4-piperidinyl]-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1(4H)-quinolineacetamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
25mg
95%
in stock  
$1,303.00   $912.00
- +
50mg
95%
in stock  
$2,254.00   $1,578.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00CL7R
Chemical Name:
2-[[(2,3-Difluorophenyl)methyl]thio]-N-[1-(2-methoxyethyl)-4-piperidinyl]-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1(4H)-quinolineacetamide
CAS Number:
412950-08-4
Molecular Formula:
C40H38F5N3O3S
Molecular Weight:
735.8050
MDL Number:
MFCD13195581
SMILES:
COCCN1CCC(CC1)N(C(=O)Cn1c(SCc2cccc(c2F)F)cc(=O)c2c1cccc2)Cc1ccc(cc1)c1ccc(cc1)C(F)(F)F
Properties
Properties
 
Storage:
-20 ℃;  

Computed Properties
 
Complexity:
1200  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
52  
Hydrogen Bond Acceptor Count:
11  
Rotatable Bond Count:
12  
XLogP3:
8.1  

Literature

Title: Darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in diabetic macular edema: a 3-month placebo-controlled study.

Journal: Ophthalmology 20150501

Title: Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study.

Journal: Atherosclerosis 20140801

Title: Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study.

Journal: Alzheimer's research & therapy 20120101

Title: Lipoprotein-associated phospholipase A(2) and atherosclerosis.

Journal: Current opinion in lipidology 20091001

Title: Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

Journal: Nature 19950406

Title: Shaddinger BC, et al. Platelet aggregation unchanged by lipoprotein-associated phospholipase A₂ inhibition: results from an in vitro study and two randomized phase I trials. PLoS One. 2014 Jan 27;9(1):e83094.

Title: Athanasios Papakyriakou, et al. Computational Investigation of Darapladib and Rilapladib Binding to Platelet Activating Factor Receptor. A Possible Mechanism of Their Involvement in Atherosclerosis. International Journal of Chemistry; Vol. 6, No. 1; 2014.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 412950-08-4
Tags:412950-08-4 Molecular Formula|412950-08-4 MDL|412950-08-4 SMILES|412950-08-4 2-[[(2,3-Difluorophenyl)methyl]thio]-N-[1-(2-methoxyethyl)-4-piperidinyl]-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1(4H)-quinolineacetamide
Catalog No.: AA00CL7R
412950-08-4,MFCD13195581
412950-08-4 | 2-[[(2,3-Difluorophenyl)methyl]thio]-N-[1-(2-methoxyethyl)-4-piperidinyl]-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1(4H)-quinolineacetamide
Pack Size: 25mg
Purity: 95%
in stock
$1,303.00 $912.00
Pack Size: 50mg
Purity: 95%
in stock
$2,254.00 $1,578.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00CL7R
Chemical Name: 2-[[(2,3-Difluorophenyl)methyl]thio]-N-[1-(2-methoxyethyl)-4-piperidinyl]-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1(4H)-quinolineacetamide
CAS Number: 412950-08-4
Molecular Formula: C40H38F5N3O3S
Molecular Weight: 735.8050
MDL Number: MFCD13195581
SMILES: COCCN1CCC(CC1)N(C(=O)Cn1c(SCc2cccc(c2F)F)cc(=O)c2c1cccc2)Cc1ccc(cc1)c1ccc(cc1)C(F)(F)F
Properties
Storage: -20 ℃;  
Complexity: 1200  
Covalently-Bonded Unit Count: 1  
Heavy Atom Count: 52  
Hydrogen Bond Acceptor Count: 11  
Rotatable Bond Count: 12  
XLogP3: 8.1  
Literature fold

Title: Darapladib, a lipoprotein-associated phospholipase A2 inhibitor, in diabetic macular edema: a 3-month placebo-controlled study.

Journal: Ophthalmology20150501

Title: Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study.

Journal: Atherosclerosis20140801

Title: Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study.

Journal: Alzheimer's research & therapy20120101

Title: Lipoprotein-associated phospholipase A(2) and atherosclerosis.

Journal: Current opinion in lipidology20091001

Title: Anti-inflammatory properties of a platelet-activating factor acetylhydrolase.

Journal: Nature19950406

Title: Shaddinger BC, et al. Platelet aggregation unchanged by lipoprotein-associated phospholipase A₂ inhibition: results from an in vitro study and two randomized phase I trials. PLoS One. 2014 Jan 27;9(1):e83094.

Title: Athanasios Papakyriakou, et al. Computational Investigation of Darapladib and Rilapladib Binding to Platelet Activating Factor Receptor. A Possible Mechanism of Their Involvement in Atherosclerosis. International Journal of Chemistry; Vol. 6, No. 1; 2014.

Building Blocks More >
317356-27-7
317356-27-7
(2S,4S)-1-(tert-Butoxycarbonyl)-4-fluoro-2-hydroxymethylpyrrolidine
AA00CLFH | MFCD19440847
402832-76-2
402832-76-2
2-(2-fluoro-4-Methoxyphenyl)ethanaMine
AA00CLM4 | MFCD08449040
364607-53-4
364607-53-4
N-BOC 2-Bromo-4-methylaniline
AA00CLQY | MFCD11976466
41931-13-9
41931-13-9
4,5-Dichloro-2-(m-tolyl)pyridazin-3(2H)-one
AA00CLZ0 | MFCD00814448
38470-26-7
38470-26-7
6-Fluoro-2,3-dihydroquinolin-4(1H)-one
AA00CMA5 | MFCD09834919
347146-17-2
347146-17-2
tert-Butyl 8-bromoquinolin-3-ylcarbamate
AA00CMKU | MFCD26383633
33924-54-8
33924-54-8
4-(2-(5-CHOLRO-2-METHOXY BENZAMIDO)ETHYL)BENZENESULFONYL CHLORIDE
AA00CMV3 | MFCD02693296
356570-53-1
356570-53-1
2-(2,5-Dimethyl-phenyl)-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane
AA00CN93 | MFCD12405520
324579-96-6
324579-96-6
Acetamide, N-(4-cyclopropyl-2-thiazolyl)-
AA00CNMB | MFCD01794602
3771-76-4
3771-76-4
Benzofuran, 2-(2-oxiranyl)-
AA00CPEP | MFCD09803890
Submit
© 2017 AA BLOCKS, INC. All rights reserved.